A government body has been assigned to evaluate the recommendations of financial penalties for price-fixing violations, according to reports, in a move that could lead to higher fines for anticompetitive corporate behavior.
The US Sentencing Commission first identified price-fixing as a potential area of study last month. Now, say reports, the group, made up mostly of judges, could raise the recommended range of financial penalties and prison sentences for price-fixing.
Antitrust experts have previously suggested that current ranges of those penalties are far too low to act as an effective deterrent to price manipulation. A study conducted in 2012, for example, found that price-fixing sanctions would need to be about five times higher to counter the negative financial effects on consumers.
American Antitrust Institute President Bert Foer said that “there’s reason to think that the level of fines imposed on miscreants is not as high as it ought to be, given the harm that is done.” The AAI had requested the Sentencing Commission to review price-fixing fines last year, according to reports.
Full content: Bangor Daily News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas